These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27504926)

  • 1. The Availability of Ancillary Counseling in the Practices of Physicians Prescribing Buprenorphine.
    Barry DT; Fazzino T; Necrason E; Ginn J; Fiellin LE; Fiellin DA; Moore BA
    J Addict Med; 2016; 10(5):352-6. PubMed ID: 27504926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine prescribing practice trends and attitudes among New York providers.
    Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD
    J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
    Rhee TG; Rosenheck RA
    Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steps physicians report taking to reduce diversion of buprenorphine.
    Yang A; Arfken CL; Johanson CE
    Am J Addict; 2013; 22(3):184-7. PubMed ID: 23617857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
    Wen H; Hockenberry JM; Pollack HA
    JAMA Netw Open; 2018 Sep; 1(5):e182943. PubMed ID: 30646185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid Use Disorder Practice by Licensure Category in North Carolina.
    Hughes PM; Harless C; Ramage M; Fusco C; Ostrach B
    N C Med J; 2023 May; 84(3):188-193. PubMed ID: 39302287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to primary care physicians prescribing buprenorphine.
    Hutchinson E; Catlin M; Andrilla CH; Baldwin LM; Rosenblatt RA
    Ann Fam Med; 2014; 12(2):128-33. PubMed ID: 24615308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice Predictors of Buprenorphine Prescribing by Family Physicians.
    Peterson LE; Morgan ZJ; Borders TF
    J Am Board Fam Med; 2020; 33(1):118-123. PubMed ID: 31907252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007-2017.
    McBain RK; Dick A; Sorbero M; Stein BD
    Ann Intern Med; 2020 Apr; 172(7):504-506. PubMed ID: 31905379
    [No Abstract]   [Full Text] [Related]  

  • 11. Family Physicians Play Key Role in Bridging the Gap in Access to Opioid Use Disorder Treatment.
    Abraham R; Wilkinson E; Jabbarpour Y; Bazemore A
    Am Fam Physician; 2020 Jul; 102(1):10. PubMed ID: 32603069
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
    DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
    Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-Career and Graduating Physicians More Likely to Prescribe Buprenorphine.
    Peterson LE; Morgan ZJ; Eden AR
    J Am Board Fam Med; 2020; 33(1):7-8. PubMed ID: 31907240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
    Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
    Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Office-Based Buprenorphine Prescribers for Medicare Patients.
    Abraham R; Wilkinson E; Jabbarpour Y; Petterson S; Bazemore A
    J Am Board Fam Med; 2020; 33(1):9-16. PubMed ID: 31907241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency.
    Suzuki J; Connery HS; Ellison TV; Renner JA
    Am J Addict; 2014; 23(6):618-22. PubMed ID: 25065457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians.
    Edelman EJ; Dinh AT; Moore BA; Schottenfeld RS; Fiellin DA; Sullivan LE
    J Addict Med; 2012 Jun; 6(2):159-65. PubMed ID: 22367499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U.S. Survey of factors associated with adherence to standard of care in treating pregnant women with opioid use disorder.
    Howard HG; Freeman K
    J Psychosom Obstet Gynaecol; 2020 Mar; 41(1):74-81. PubMed ID: 31244358
    [No Abstract]   [Full Text] [Related]  

  • 19. Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.
    Stein BD; Saloner B; Schuler MS; Gurvey J; Sorbero M; Gordon AJ
    JAMA; 2021 Jun; 325(21):2206-2208. PubMed ID: 34061152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary results of the evaluation of the California Hub and Spoke Program.
    Darfler K; Sandoval J; Pearce Antonini V; Urada D
    J Subst Abuse Treat; 2020 Jan; 108():26-32. PubMed ID: 31400985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.